Context: COVID-19 is a global public health problem and diabetes mellitus is a poor prognostic factor for the disease. The aim of this study was to investigate the epidemiological, clinical and evolutionary characteri...Context: COVID-19 is a global public health problem and diabetes mellitus is a poor prognostic factor for the disease. The aim of this study was to investigate the epidemiological, clinical and evolutionary characteristics of COVID-19 in diabetic patients in Bouaké. Patients and Methods: This was a retrospective study carried out from January 2021 to December 2022. We included patients with diabetes known before COVID-19 infection and having a positive COVID-19 RT-PCR. Data were analyzed with Epi info7 software. Results: Among 1122 infected patients, 71 patients (6.3%) were diabetic, the sex ratio was 1.3 and the mean age was 58.7 years. Type 2 diabetes (97.2%) was predominant and the average seniority was 3.1 years. Arterial hypertension (46.5%) was the main comorbidity. The main clinical signs were cough (69%), dyspnea (43.7%) and fever (23.9%). Oxygen saturation was Conclusion: Diabetes mellitus remains one of the most important comorbidities of severe Covid-19. The death rate of diabetics was high. Hence the need to vaccinate people living with diabetes.展开更多
Introduction: The clinical manifestations of many diseases vary with age, and older people often do not show typical symptoms of the disease. The present study aims to compare the epidemiological, clinical, therapeuti...Introduction: The clinical manifestations of many diseases vary with age, and older people often do not show typical symptoms of the disease. The present study aims to compare the epidemiological, clinical, therapeutic and evolutionary aspects of elderly patients with COVID-19 compared to young adult patients and to identify risk factors for mortality. Patients and Methods: This was a retrospective single-center analytical study conducted from January 27, 2021 to January 27, 2022 at the COVID-19 Care Center of the Infectious and Tropical Diseases Department of the Bouaké University Teaching Hospital. The study population consisted of all patients aged at least 18 years seen in consultation and/or hospitalized with a positive COVID-19 RT-PCR. The patients were divided into two groups: younger patients (Results: Of a total of 779 patients, 644 (82.7%) were young. The median age of all patients was 41 years (IQR 32 - 54, extreme 18 and 96). Of all the patients 38.5% had a comorbidity. Compared to younger patients, chronic heart disease (61.7% vs 21.5%;p Conclusion: Elderly people with COVID-19 have a different clinical presentation from younger, characterized by more atypical symptoms. Mortality risk factors are age, dyspnoea, impaired consciousness and fever. It is therefore necessary to act on its various factors to improve the prognosis of COVID-19 in this age group.展开更多
文摘Context: COVID-19 is a global public health problem and diabetes mellitus is a poor prognostic factor for the disease. The aim of this study was to investigate the epidemiological, clinical and evolutionary characteristics of COVID-19 in diabetic patients in Bouaké. Patients and Methods: This was a retrospective study carried out from January 2021 to December 2022. We included patients with diabetes known before COVID-19 infection and having a positive COVID-19 RT-PCR. Data were analyzed with Epi info7 software. Results: Among 1122 infected patients, 71 patients (6.3%) were diabetic, the sex ratio was 1.3 and the mean age was 58.7 years. Type 2 diabetes (97.2%) was predominant and the average seniority was 3.1 years. Arterial hypertension (46.5%) was the main comorbidity. The main clinical signs were cough (69%), dyspnea (43.7%) and fever (23.9%). Oxygen saturation was Conclusion: Diabetes mellitus remains one of the most important comorbidities of severe Covid-19. The death rate of diabetics was high. Hence the need to vaccinate people living with diabetes.
文摘Introduction: The clinical manifestations of many diseases vary with age, and older people often do not show typical symptoms of the disease. The present study aims to compare the epidemiological, clinical, therapeutic and evolutionary aspects of elderly patients with COVID-19 compared to young adult patients and to identify risk factors for mortality. Patients and Methods: This was a retrospective single-center analytical study conducted from January 27, 2021 to January 27, 2022 at the COVID-19 Care Center of the Infectious and Tropical Diseases Department of the Bouaké University Teaching Hospital. The study population consisted of all patients aged at least 18 years seen in consultation and/or hospitalized with a positive COVID-19 RT-PCR. The patients were divided into two groups: younger patients (Results: Of a total of 779 patients, 644 (82.7%) were young. The median age of all patients was 41 years (IQR 32 - 54, extreme 18 and 96). Of all the patients 38.5% had a comorbidity. Compared to younger patients, chronic heart disease (61.7% vs 21.5%;p Conclusion: Elderly people with COVID-19 have a different clinical presentation from younger, characterized by more atypical symptoms. Mortality risk factors are age, dyspnoea, impaired consciousness and fever. It is therefore necessary to act on its various factors to improve the prognosis of COVID-19 in this age group.
